Effects of 5′ Regulatory-Region Polymorphisms on Paraoxonase-Gene (PON1) Expression
Top Cited Papers
- 1 June 2001
- journal article
- Published by Elsevier BV in American Journal of Human Genetics
- Vol. 68 (6), 1428-1436
- https://doi.org/10.1086/320600
Abstract
No abstract availableThis publication has 55 references indexed in Scilit:
- Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6Published by Elsevier BV ,2001
- Short-Term Feeding of Atherogenic Diet to Mice Results in Reduction of HDL and Paraoxonase That May Be Mediated by an Immune MechanismArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Mutations in the human paraoxonase 1 genePharmacogenetics, 1999
- Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid AtherosclerosisStroke, 1998
- Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase ActivitiesArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Human Serum ParaoxonaseGeneral Pharmacology: The Vascular System, 1998
- Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.JCI Insight, 1998
- Two Alleles of the Human Paraoxonase Gene Produce Different Amounts of mRNAArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Serum paraoxonase status: A major factor in determining resistance to organophosphatesJournal of Toxicology and Environmental Health, 1993
- Human and rabbit paraoxonases: Purification, cloning, sequencing, mapping and role of polymorphism in organophosphate detoxificationChemico-Biological Interactions, 1993